Considering the wide distribution of germline pathogenic variants in TP53 in Brazilian individuals and the association with early-onset breast cancer, we investigated the presence of TP53 variants in a cohort of breast cancer patients from the unexplored central region of Brazil. Here, TP53 is linked to breast carcinoma.